Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Einstein (Sao Paulo) ; 21: eAO0405, 2023.
Article in English | MEDLINE | ID: mdl-37970951

ABSTRACT

OBJECTIVE: To verify the involvement of the endocannabinoid system in the immunomodulatory profile of stem cells from human exfoliated deciduous teeth, in the presence or absence of TNF-α, and agonist and antagonists of CB1 and CB2. METHODS: Stem cells from human exfoliated deciduous teeth were cultured in the presence or absence of an agonist, anandamide, and two antagonists, AM251 and SR144528, of CB1 and CB2 receptors, with or without TNF-α stimulation. For analysis of immunomodulation, surface molecules linked to immunomodulation, namely human leukocyte antigen-DR isotype (HLA-DR), and programmed death ligands 1 (PD-L1) and 2 (PD-L2) were measured using flow cytometry. RESULTS: The inhibition of endocannabinoid receptors together with the proinflammatory effect of TNF-α resulted in increased HLA-DR expression in stem cells from human exfoliated deciduous teeth, as well as, in these cells acquiring an anti-inflammatory profile by enhancing the expression of PD-L1 and PD-L2. CONCLUSION: Stem cells from human exfoliated deciduous teeth respond to the endocannabinoid system and TNF-α by altering key immune response molecules. Inhibition of endocannabinoid receptors and TNF-α led to an increase in HLA-DR, PD-L1, and PD-L2 levels in stem cells from human exfoliated deciduous teeth. This study shows the interaction between mesenchymal stromal cells and the immune and endocannabinoid systems.


Subject(s)
B7-H1 Antigen , Tumor Necrosis Factor-alpha , Humans , B7-H1 Antigen/metabolism , B7-H1 Antigen/pharmacology , Cell Differentiation/physiology , Cells, Cultured , Endocannabinoids/pharmacology , Endocannabinoids/metabolism , HLA-DR Antigens/metabolism , HLA-DR Antigens/pharmacology , Receptors, Cannabinoid/metabolism , Stem Cells/metabolism , Tooth, Deciduous
2.
Braz. J. Pharm. Sci. (Online) ; 59: e23075, 2023. graf
Article in English | LILACS | ID: biblio-1505836

ABSTRACT

Abstract Focal Adhesion Kinase (FAK) protein participates in proliferation, migration, cell survival, and apoptosis process. It has been described as overexpressed in several neoplasms being a promising target for therapy. BCR-ABL negative chronic Myeloproliferative Neoplasms (MPN) are clonal disorders characterized by the excess of proliferation and apoptosis resistance. The identification of the acquired JAK2 V617F mutation in MPN patients allowed a better understanding of pathogenesis. However, there is still no pharmacological treatment that leads all patients to molecular remission, justifying new studies. The present study aimed to evaluate FAK involvement in the viability and apoptosis of HEL and SET-2 cells, both JAK2 V617F positive cell lines. The FAK inhibitor PF 562,271 was used. Cell viability was determined using MTT assay and apoptosis verified by cleaved PARP, cleaved Caspase 3 and Annexin-V/PI staining detection. FAK inhibition significantly reduced HEL and SET-2 cells viability and induced apoptosis. Considering the role of JAK/STAT pathway in MPN, further investigation of FAK participation in the MPN cells proliferation and apoptosis resistance, as well as possible crosstalk between JAK and FAK and downstream pathways may contribute to the knowledge of MPN pathophysiology, the discovery of new molecular targets, and JAK inhibitors resistance mechanisms.


Subject(s)
Apoptosis , Focal Adhesion Protein-Tyrosine Kinases/analysis , Janus Kinase 2/adverse effects , Patients/classification , Cell Line/classification , Neoplasms/pathology
3.
Einstein (Säo Paulo) ; 21: eAO0405, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1520851

ABSTRACT

ABSTRACT Objective To verify the involvement of the endocannabinoid system in the immunomodulatory profile of stem cells from human exfoliated deciduous teeth, in the presence or absence of TNF-α, and agonist and antagonists of CB1 and CB2. Methods Stem cells from human exfoliated deciduous teeth were cultured in the presence or absence of an agonist, anandamide, and two antagonists, AM251 and SR144528, of CB1 and CB2 receptors, with or without TNF-α stimulation. For analysis of immunomodulation, surface molecules linked to immunomodulation, namely human leukocyte antigen-DR isotype (HLA-DR), and programmed death ligands 1 (PD-L1) and 2 (PD-L2) were measured using flow cytometry. Results The inhibition of endocannabinoid receptors together with the proinflammatory effect of TNF-α resulted in increased HLA-DR expression in stem cells from human exfoliated deciduous teeth, as well as, in these cells acquiring an anti-inflammatory profile by enhancing the expression of PD-L1 and PD-L2. Conclusion Stem cells from human exfoliated deciduous teeth respond to the endocannabinoid system and TNF-α by altering key immune response molecules.

4.
Autoimmunity ; 49(4): 258-67, 2016 06.
Article in English | MEDLINE | ID: mdl-26911613

ABSTRACT

Experimental autoimmune encephalomyelitis (EAE) is a model for the study of multiple sclerosis, which is an inflammatory and demyelinating disease of the central nervous system (CNS). Despite increased efforts to elucidate the function of toll-like receptors (TLRs) in autoimmune diseases of the CNS, the relative contribution of other factors, including the immunomodulatory properties of TLR signaling, role of the innate response and the presence or absence of myelin peptides remain unclear. The aim was to evaluate TLR expression in the CNS during EAE development by investigating the expression of TLRs in the initial phase of EAE and establishing correlations with the modulation of inflammatory factors. Mice were subcutaneously immunized at the tail base with 100 µg of myelin oligodendrocyte glycoprotein peptide (MOG35-55), emulsified in complete Freund's adjuvant (CFA) supplemented with 400 µg of attenuated Mycobacterium tuberculosis H37RA. Pertussis toxin (300 ng per animal) was intraperitoneally injected on the day of immunization and 48 h later. Another group (MOG(-)) received an equal emulsion of CFA and M. tuberculosis, without MOG35-55, and the same protocol of Pertussis toxin. The immunized mice presented signs of disease with increased IFN-γ production and presence of NK cells on Day 2 postimmunization and reduced the expression of TLR-3 and TLR-9. In the spinal cord, CCL5 and CCL20 were higher in EAE. This study establishes a correlation between TLR-3 and TLR-9 expression with the development of EAE. In addition, evidence of a role for the myelin peptide in targeting the innate inflammatory response to the CNS is presented.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/etiology , Encephalomyelitis, Autoimmune, Experimental/metabolism , Gene Expression , Interferon-gamma/biosynthesis , Myelin Sheath/immunology , Toll-Like Receptor 3/genetics , Toll-Like Receptor 9/genetics , Animals , Biomarkers , Cytokines/metabolism , Encephalomyelitis, Autoimmune, Experimental/diagnosis , Female , Immunophenotyping , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Lymph Nodes/immunology , Lymph Nodes/metabolism , Lymph Nodes/pathology , Lymphocytes/immunology , Lymphocytes/metabolism , Mice , Myelin-Oligodendrocyte Glycoprotein/immunology , Peptide Fragments/immunology , Spinal Cord/immunology , Spinal Cord/metabolism , Spinal Cord/pathology , Toll-Like Receptor 3/metabolism , Toll-Like Receptor 9/metabolism
5.
Cell Immunol ; 293(2): 87-94, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25585346

ABSTRACT

Multiple sclerosis (MS) shows distinct clinical courses. Experimental autoimmune encephalomyelitis (EAE), a model to study multiple sclerosis, can be induced by different protocols, which show distinct cytokine and antibody production. The factors involved in this heterogeneity remain unclear. The relevance of MOG concentration in triggering a regulatory response in the chronic model of EAE is imprecise. The aim of this study was investigate if 100 or 300 µg of MOG(35-55) could induce different EAE profiles. Modifications in the concentration of MOG were able to change the patterns of chemokines, cytokines, percentage of cells, inflammatory infiltrate and the development of a regulatory response. However, these changes were unable to modify the intensity of response, which explains the chronic progression of the disease in both concentrations. The results presented in this study contribute to understanding the intricate mechanisms that trigger EAE and provide insights into the pathogenesis of various forms of MS.


Subject(s)
Brain/immunology , Encephalomyelitis, Autoimmune, Experimental/immunology , Inflammation/immunology , Myelin-Oligodendrocyte Glycoprotein/administration & dosage , Spinal Cord/immunology , Animals , Brain/pathology , Chemokines/analysis , Disease Models, Animal , Encephalomyelitis, Autoimmune, Experimental/pathology , Female , Flow Cytometry , Mice , Mice, Inbred C57BL , Spinal Cord/pathology , Statistics, Nonparametric
6.
HU rev ; 37(4): 495-501, dez. 2011.
Article in Portuguese | LILACS | ID: lil-661239

ABSTRACT

A eficácia do Bacilo Calmette Guerin (BCG) é baixa e a incidência de tuberculose é elevada em áreas onde os helmintos são endêmicos. Enquanto a proteção contra a tuberculose exige forte imunidade celular, infecções helmínticas crônicas induzem respostas caracterizadas pelo perfil Th2, bem como o aumento da atividade de células T reguladoras. Portanto, infecções helmínticas crônicas poderiam modular a resposta imunológica necessária para controlar a infecção por micobactérias e/ou a eficácia da vacinação com BCG.


The effectiveness of Bacille Calmette Guerin (BCG) is low and the incidence of tuberculosis is high in areas where helminths are endemic. While protection against tuberculosis requires strong cellular immunity, chronic helminth infections induce responses characterized by Th2 profile, as well as increased T regulatory cell activity. Therefore, chronic helminth infection could modulate the immune response needed to control mycobacterial infection and/or the efficacy of vaccination against tuberculosis


Subject(s)
Tuberculosis , Mycobacterium tuberculosis , BCG Vaccine , Vaccination , Disease Susceptibility , Helminths , Immunity, Cellular , Infections , Mycobacterium
7.
Ann Allergy Asthma Immunol ; 106(6): 481-8, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21624747

ABSTRACT

BACKGROUND: Asthma is a disease characterized by intermittent obstruction of the airways and chronic inflammation that affects approximately 300 million people worldwide. The immune response in asthma is predominantly T(H)2, with high levels of total and allergen-specific IgE and bronchial eosinophilia. Asthma treatment is aimed at controlling the disease, and the drugs used currently have systemic adverse effects and generally are not effective in difficult-to-control cases. OBJECTIVE: To investigate the effect of aqueous extract of Echinodorus grandiflorus, a plant used in folk medicine for its diuretic and anti-inflammatory properties, in a model of pulmonary allergy. METHODS: BALB/c mice were intraperitoneally sensitized and nasally challenged with ovalbumin. Aqueous extract and dexamethasone treatments (0.1 mL/d per mouse) were initiated on day 32 and concluded on day 40. Eight hours after the last challenge evaluations, of serum, bronchoalveolar lavage, and lung tissue were performed. RESULTS: Oral treatment with the extract markedly reduced the number of total cells and eosinophils in bronchoalveolar lavage. The eosinophil peroxidase activity in lung tissue, the levels of ovalbumin-specific IgE in serum, the levels of CCL11, and the gene expression of interleukin 4 and interleukin 13 in lung tissue were also lower after treatment. CONCLUSIONS: These results suggest that the aqueous extract of E grandiflorus is able to modulate allergic pulmonary inflammation and may be useful as a potential therapeutic agent for asthma.


Subject(s)
Alismataceae , Asthma/drug therapy , Lung Diseases/drug therapy , Plant Extracts/therapeutic use , Respiratory Hypersensitivity/drug therapy , Animals , Asthma/immunology , Bronchoalveolar Lavage Fluid/immunology , Chemokine CCL11/metabolism , Dexamethasone/administration & dosage , Dexamethasone/therapeutic use , Disease Models, Animal , Eosinophil Peroxidase/metabolism , Immunoglobulin E/blood , Interleukin-13/metabolism , Interleukin-4/metabolism , Lung/immunology , Medicine, Traditional , Mice , Mice, Inbred BALB C , Ovalbumin/immunology , Respiratory Hypersensitivity/immunology , Reverse Transcriptase Polymerase Chain Reaction
8.
Mem Inst Oswaldo Cruz ; 104(7): 1039-41, 2009 Nov.
Article in English | MEDLINE | ID: mdl-20027475

ABSTRACT

Chemokines recruit and activate leukocytes, assisting granuloma formation. Herein, we evaluated plasma chemokines in patients with active tuberculosis (ATB) and after completing treatment (TTB) and compared them to BCG-vaccinated healthy controls (HC). Levels of chemokines were measured by cytometric bead array. Levels of CXCL8, CXCL9 and CXCL10 were higher in ATB patients compared to HC, but they decreased in TTB. Levels of CCL2 and CCL5 in ATB patients were similar to those observed in HC. Thus, the high levels of CXC-chemokines detected during ATB, which can modulate the trafficking of immune cells from the periphery to the site of infection, were reversed by anti-mycobacterial treatment.


Subject(s)
Antibiotics, Antitubercular/therapeutic use , Chemokines, CXC/blood , Tuberculosis, Pulmonary/blood , Tuberculosis, Pulmonary/drug therapy , Adolescent , Adult , Aged , BCG Vaccine , Case-Control Studies , Chemokines, CXC/analysis , Female , Flow Cytometry/methods , Humans , Male , Middle Aged , Statistics, Nonparametric , Time Factors , Treatment Outcome , Young Adult
9.
Mem. Inst. Oswaldo Cruz ; 104(7): 1039-1041, Nov. 2009. ilus
Article in English | LILACS | ID: lil-534173

ABSTRACT

Chemokines recruit and activate leukocytes, assisting granuloma formation. Herein, we evaluated plasma chemokines in patients with active tuberculosis (ATB) and after completing treatment (TTB) and compared them to BCG-vaccinated healthy controls (HC). Levels of chemokines were measured by cytometric bead array. Levels of CXCL8, CXCL9 and CXCL10 were higher in ATB patients compared to HC, but they decreased in TTB. Levels of CCL2 and CCL5 in ATB patients were similar to those observed in HC. Thus, the high levels of CXC-chemokines detected during ATB, which can modulate the trafficking of immune cells from the periphery to the site of infection, were reversed by anti-mycobacterial treatment.


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Antibiotics, Antitubercular/therapeutic use , Chemokines, CXC/blood , Tuberculosis, Pulmonary/blood , Tuberculosis, Pulmonary/drug therapy , BCG Vaccine , Case-Control Studies , Chemokines, CXC/analysis , Flow Cytometry/methods , Statistics, Nonparametric , Time Factors , Treatment Outcome , Young Adult
10.
Chem Pharm Bull (Tokyo) ; 55(2): 223-6, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17268092

ABSTRACT

Fourteen thalidomide analogs bearing two phthalimido units were prepared in high yields (83-94%) by condensation of different diamines with phthalic or 3-nitrophthalic anhydride. An in vitro investigation of the compounds as inhibitors of the TNF-alpha production was performed. The inhibition was higher for compounds bearing amino and nitro groups and was modulated by increasing the size of the spacers between the phthalimide groups.


Subject(s)
Diamines/chemistry , Thalidomide/chemical synthesis , Thalidomide/pharmacology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Angiogenesis Inhibitors/pharmacology , Immunosuppressive Agents/pharmacology , Leprostatic Agents/pharmacology , Phthalic Anhydrides/chemistry , Phthalimides/chemistry , Stereoisomerism , Structure-Activity Relationship , Thalidomide/analogs & derivatives , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...